A Study of Abemaciclib in Recurrent Glioblastoma
A Study of Abemaciclib in Recurrent Glioblastoma
Active, not recruiting · NCT02981940 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Abemaciclib in Recurrent Glioblastoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-04 | NCT02981940 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Eli Lilly and Company | 370 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Huntsman Cancer Institute | Salt Lake City | United States | 107 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Memorial Sloan-Kettering Cancer Center | New York | United States | 4 |
| University of California Los Angeles | Los Angeles | United States | 87 |
| University of California, San Francisco | San Francisco | United States | 2 |
| UT, M.D. Anderson Cancer Center | Houston | United States | 1 |